Related Experiment Videos

Treatment of combined coronary and carotid artery disease

Joseph Huh1, Matthew J Wall, Ernesto R Soltero

  • 1Division of Cardiothoracic Surgery, Houston Veterans Affairs Medical Center, Ben Taub General Hospital, Baylor College of Medicine, Houston, Texas 77401, USA. joseph.huh@med.va.gov

Current Opinion in Cardiology
|November 5, 2003
PubMed

Insights

Treating combined coronary and carotid disease remains challenging. Staged procedures may offer lower stroke rates, but all surgical options carry risks for advanced atherosclerosis patients.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Atherosclerosis Research

Background:

  • Combined coronary and carotid disease presents a significant management challenge.
  • Advanced atherosclerosis complicates treatment decisions for these patients.

Purpose of the Study:

  • To evaluate current treatment indications and outcomes for combined coronary and carotid disease.
  • To review surgical management strategies for patients with synchronous coronary and carotid stenosis.

Main Methods:

  • Review of recent case series and meta-analyses on surgical interventions.
  • Comparison of outcomes for staged versus combined synchronous surgical approaches.

Main Results:

  • Approximately 8% of patients evaluated for coronary artery bypass grafting have significant carotid stenosis (>70%).
  • Staged procedures showed a trend toward lower stroke rates compared to combined procedures.
  • Overall morbidity and mortality risks were higher for combined disease compared to single-territory procedures.

Conclusions:

  • Treatment indications and surgical options for combined coronary and carotid disease remain controversial.
  • Advocacy for treating the symptomatic territory first using staged procedures.
  • Combined procedures are reserved for patients with critical stenosis or symptoms in both territories.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...